Despite surgical improvements, pseudophakic cystoid macular edema (CME) is the most common cause of decreased vision after cataract surgery and could lead to permanently impaired central vision owing to altered outer photoreceptor features. In this study, we aimed to determine the age- and sex-specific incidence of CME after primary uncomplicated phacoemulsification in community-based outpatient clinics in the Languedoc-Roussillon region of France. The secondary objective was to assess the characteristics of CME, including time of onset and duration.

Study finds that glaucoma patients are at higher risk for complications and show weaker visual improvement.

AGTC has filed a new drug application with the FDA to conduct a clinical trial of a gene therapy product to treat achromatopsia.

Case report brings to light a potentially under-diagnosed cause of ocular neuropathic pain – vitamin B12 deficiency.

Literature review finds no evidence to support routine use of NSAIDs after cataract surgery to prevent vision loss from CME.

To report visual outcomes in patients undergoing proton beam irradiation of tumors located within 1 disc diameter of the fovea.